NEWLINK GENETICS CORP's ticker is NLNK and the CUSIP is 651511107. A total of 156 filers reported holding NEWLINK GENETICS CORP in Q3 2015. The put-call ratio across all filers is 0.59 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $236,000 | +124.8% | 9,800 | -3.9% | 0.04% | +104.8% |
Q4 2016 | $105,000 | -31.4% | 10,200 | 0.0% | 0.02% | -32.3% |
Q3 2016 | $153,000 | +33.0% | 10,200 | 0.0% | 0.03% | +29.2% |
Q2 2016 | $115,000 | -38.2% | 10,200 | 0.0% | 0.02% | -41.5% |
Q1 2016 | $186,000 | -47.9% | 10,200 | +4.1% | 0.04% | -47.4% |
Q4 2015 | $357,000 | +1.7% | 9,800 | 0.0% | 0.08% | -12.4% |
Q3 2015 | $351,000 | -20.8% | 9,800 | -2.0% | 0.09% | -15.2% |
Q2 2015 | $443,000 | -49.4% | 10,000 | -37.5% | 0.10% | -46.2% |
Q1 2015 | $875,000 | +4.8% | 16,000 | -23.8% | 0.20% | -6.2% |
Q4 2014 | $835,000 | +49.9% | 21,000 | -19.2% | 0.21% | +38.7% |
Q3 2014 | $557,000 | -19.3% | 26,000 | 0.0% | 0.15% | -19.8% |
Q2 2014 | $690,000 | -6.5% | 26,000 | 0.0% | 0.19% | -19.7% |
Q1 2014 | $738,000 | +11.8% | 26,000 | -13.3% | 0.23% | +5.0% |
Q4 2013 | $660,000 | -21.2% | 30,000 | -26.5% | 0.22% | -30.2% |
Q3 2013 | $838,000 | +1.8% | 40,826 | 0.0% | 0.32% | -16.5% |
Q2 2013 | $823,000 | – | 40,826 | – | 0.38% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
FT Options LLC | 21,900 | $1,292,000 | 1.11% |
TIVERTON ASSET MANAGEMENT LLC | 288,807 | $18,215,000 | 0.77% |
Knoll Capital Management, LLC | 102,437 | $1,153,000 | 0.37% |
BOGLE INVESTMENT MANAGEMENT L P /DE/ | 460,146 | $5,181,000 | 0.36% |
WALL STREET ASSOCIATES | 79,000 | $890,000 | 0.36% |
Endurant Capital Management LP | 62,491 | $704,000 | 0.24% |
FT Options LLC | 21,903 | $247,000 | 0.21% |
Virtus ETF Advisers LLC | 24,463 | $275,000 | 0.20% |
Orbimed Advisors | 1,581,506 | $17,808,000 | 0.19% |
HAP Trading, LLC | 227,728 | $2,564,000 | 0.15% |